← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Bohjalian Thomas N
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001354287
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 6
- Purchases · 24M
- 12
- Average purchase
- $125.7K
- Median purchase
- $109.4K
- Gross purchase value
- $1.5M
Companies: Healthcare Realty Trust Inc | SmartRent, Inc.
12 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-08-20 | SmartRent, Inc. | SMRT | Director | $76.5K | Open filing |
| 2026-08-12 | SmartRent, Inc. | SMRT | Director | $6.7K | Open filing |
| 2026-06-10 | SmartRent, Inc. | SMRT | Director | $83.3K | Open filing |
| 2026-03-12 | SmartRent, Inc. | SMRT | Director | $261.0K | Open filing |
| 2026-03-06 | Healthcare Realty Trust Inc | HR | Director | $180.9K | Open filing |
| 2025-12-02 | SmartRent, Inc. | SMRT | Director | $84.0K | Open filing |
| 2025-08-19 | SmartRent, Inc. | SMRT | Director | $187.2K | Open filing |
| 2025-08-13 | Healthcare Realty Trust Inc | HR | Director | $164.6K | Open filing |
| 2025-08-12 | SmartRent, Inc. | SMRT | Director | $223.2K | Open filing |
| 2025-05-14 | Healthcare Realty Trust Inc | HR | Director | $36.8K | Open filing |
| 2024-11-22 | Healthcare Realty Trust Inc | HR | Director | $134.8K | Open filing |
| 2024-11-22 | Healthcare Realty Trust Inc | HR | Director | $68.8K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 7Developing | 58.3% (7/12) | 28.6% (2/7) | -1.5% | +2.2% | -4.4% |
| 20D | 7Developing | 58.3% (7/12) | 42.9% (3/7) | -9.8% | -4.0% | -18.1% |
| 60D | 5Developing | 50.0% (5/10) | 20.0% (1/5) | -7.8% | -9.4% | -42.8% |
| 120D | 4Small Sample | 44.4% (4/9) | 50.0% (2/4) | -12.3% | -10.2% | -34.1% |
Research patterns
- First purchase in 12M
- 0/10
- Large purchase ≥ $100k
- 6/12
- Cluster buying · 15D
- 7/12
- Buying the dip
- 5/7
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.